IBRX (NASDAQ) - Dividend History and Outstanding Shares
No Dividends discovered - So far (until May 2024) IBRX does not pay dividends. Outstanding Shares evolving.
No Dividends
As of May 2024, Immunitybio (IBRX) does not pay a dividend.
As of May 2024, Immunitybio (IBRX) does not pay a dividend.
Outstanding Shares
What is the Trend of IBRX`s Outstanding Shares?
The Outstanding Shares of Immunitybio are growing at a rate of 7.51% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 77.78%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.Did Immunitybio ever had a Stock Split?
No Stock Splits found.Year | Number of Shares (Mill.) | Growth |
---|---|---|
2024 | 672.83 | +0.29% |
2023 | 670.87 | +66.2% |
2022 | 403.64 | +1.64% |
2021 | 397.12 | +3.64% |
2020 | 383.18 | -2.72% |
2019 | 393.89 | +21.18% |
2018 | 325.05 | +2.81% |
2017 | 316.15 | -3.78% |
2016 | 328.55 | +0.69% |
2015 | 326.3 | +3978.74% |
2014 | 8 | +700% |
2013 | 1 |
Dividend Yields, Growth & Consistency
Overall Dividend Rating | - | ||
Dividends Paid 12m | - | Yield 12m | - |
Dividends Paid Average 5y | - | Yield Average 5y | - |
Growth Rate 5y | - | Yield on Cost 5y | - |
Payout Consistency | - | First Payout | - |
Compare IBRX Dividends with its Industry Peers |
No Dividends Paid
-- IBRX`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price.
- 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by price 5 years ago).
- The 0.0% Payout Consistency of IBRX Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
- The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases IBRX`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
Ratings surpassing 5 are regarded as favorable, while those exceeding 7.5 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.